Elizabeth C. Leritz, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parietal Lobe | 2 | 2019 | 850 | 0.820 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2013 | 953 | 0.760 |
Why?
|
| Executive Function | 7 | 2021 | 1346 | 0.760 |
Why?
|
| Apolipoprotein E4 | 2 | 2015 | 684 | 0.710 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 88 | 0.700 |
Why?
|
| Cerebral Cortex | 8 | 2017 | 5719 | 0.610 |
Why?
|
| Cholesterol | 4 | 2017 | 2881 | 0.600 |
Why?
|
| Neuropsychological Tests | 14 | 2020 | 6941 | 0.600 |
Why?
|
| Rest | 2 | 2021 | 908 | 0.550 |
Why?
|
| Diffusion Tensor Imaging | 6 | 2015 | 2350 | 0.520 |
Why?
|
| Frontal Lobe | 2 | 2019 | 1405 | 0.450 |
Why?
|
| Cerebrum | 1 | 2013 | 134 | 0.410 |
Why?
|
| Cognition | 6 | 2020 | 6785 | 0.400 |
Why?
|
| Corpus Callosum | 1 | 2015 | 729 | 0.360 |
Why?
|
| Brain Diseases | 1 | 2019 | 1539 | 0.360 |
Why?
|
| Aging | 7 | 2017 | 8492 | 0.350 |
Why?
|
| Cerebrovascular Disorders | 3 | 2015 | 1485 | 0.350 |
Why?
|
| Brain | 10 | 2021 | 26598 | 0.350 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 247 | 0.340 |
Why?
|
| Blood Glucose | 2 | 2015 | 6220 | 0.320 |
Why?
|
| Triglycerides | 1 | 2016 | 2434 | 0.310 |
Why?
|
| Brain Mapping | 4 | 2019 | 6599 | 0.300 |
Why?
|
| Aphasia | 1 | 2008 | 187 | 0.280 |
Why?
|
| Judgment | 1 | 2008 | 278 | 0.270 |
Why?
|
| Anisotropy | 3 | 2015 | 1272 | 0.250 |
Why?
|
| Aged | 25 | 2021 | 164457 | 0.230 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3670 | 0.230 |
Why?
|
| Intelligence | 1 | 2008 | 910 | 0.220 |
Why?
|
| Cognition Disorders | 3 | 2017 | 3959 | 0.210 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2006 | 386 | 0.210 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2002 | 70 | 0.200 |
Why?
|
| Neural Pathways | 3 | 2019 | 3014 | 0.190 |
Why?
|
| Memory | 2 | 2013 | 2168 | 0.190 |
Why?
|
| Blood Pressure | 4 | 2011 | 8405 | 0.190 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 57622 | 0.190 |
Why?
|
| Awareness | 1 | 2004 | 645 | 0.180 |
Why?
|
| Middle Aged | 22 | 2021 | 214698 | 0.170 |
Why?
|
| Mobility Limitation | 2 | 2020 | 403 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2006 | 1175 | 0.160 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2002 | 2102 | 0.160 |
Why?
|
| Hippocampus | 2 | 2014 | 3687 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5773 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2017 | 8906 | 0.160 |
Why?
|
| Muscle Strength | 2 | 2020 | 599 | 0.160 |
Why?
|
| Male | 29 | 2021 | 351538 | 0.160 |
Why?
|
| Self Concept | 1 | 2004 | 1011 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 35800 | 0.160 |
Why?
|
| Female | 29 | 2021 | 382565 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 3 | 2019 | 2714 | 0.140 |
Why?
|
| Disability Evaluation | 2 | 2020 | 1810 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2017 | 4403 | 0.120 |
Why?
|
| Risk Factors | 8 | 2020 | 72453 | 0.120 |
Why?
|
| Humans | 33 | 2021 | 746839 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2017 | 905 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2010 | 12658 | 0.110 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2342 | 0.110 |
Why?
|
| Metabolic Diseases | 2 | 2017 | 673 | 0.100 |
Why?
|
| Alcoholism | 2 | 2014 | 1922 | 0.100 |
Why?
|
| Adult | 18 | 2020 | 215288 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2019 | 1369 | 0.100 |
Why?
|
| Genotype | 3 | 2017 | 12790 | 0.100 |
Why?
|
| Temperance | 1 | 2011 | 87 | 0.100 |
Why?
|
| Accidental Falls | 1 | 2019 | 1035 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2013 | 2767 | 0.100 |
Why?
|
| Myelin Sheath | 1 | 2015 | 646 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 970 | 0.090 |
Why?
|
| Hypertension | 3 | 2020 | 8365 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2019 | 1161 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2020 | 1192 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2817 | 0.090 |
Why?
|
| Mental Processes | 1 | 2011 | 245 | 0.090 |
Why?
|
| Life Change Events | 1 | 2014 | 936 | 0.080 |
Why?
|
| Attention | 1 | 2019 | 2380 | 0.080 |
Why?
|
| Language Tests | 1 | 2008 | 195 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1419 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2008 | 497 | 0.070 |
Why?
|
| Verbal Behavior | 1 | 2008 | 334 | 0.070 |
Why?
|
| Veterans | 3 | 2017 | 2528 | 0.070 |
Why?
|
| Amygdala | 1 | 2014 | 1329 | 0.070 |
Why?
|
| Obesity | 2 | 2020 | 12726 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2020 | 23470 | 0.070 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 450 | 0.070 |
Why?
|
| Creatinine | 1 | 2010 | 1850 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2012 | 3307 | 0.060 |
Why?
|
| Semantics | 1 | 2008 | 600 | 0.060 |
Why?
|
| Age Factors | 2 | 2013 | 18159 | 0.060 |
Why?
|
| Cerebellum | 1 | 2012 | 1486 | 0.060 |
Why?
|
| Leg | 2 | 2020 | 1087 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2017 | 4012 | 0.060 |
Why?
|
| Functional Laterality | 2 | 2015 | 2263 | 0.060 |
Why?
|
| Range of Motion, Articular | 2 | 2020 | 1569 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2008 | 15561 | 0.050 |
Why?
|
| Models, Psychological | 1 | 2006 | 805 | 0.050 |
Why?
|
| Organ Size | 2 | 2019 | 2239 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21698 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6228 | 0.050 |
Why?
|
| Knee Joint | 2 | 2020 | 1648 | 0.050 |
Why?
|
| Educational Status | 1 | 2008 | 2486 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 618 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2000 | 149 | 0.040 |
Why?
|
| Demography | 1 | 2004 | 1630 | 0.040 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8307 | 0.040 |
Why?
|
| Task Performance and Analysis | 1 | 2002 | 760 | 0.040 |
Why?
|
| Prednisone | 1 | 2000 | 1559 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11965 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2004 | 2385 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2017 | 40538 | 0.030 |
Why?
|
| Motor Activity | 1 | 2004 | 2670 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 25194 | 0.030 |
Why?
|
| Afghan Campaign 2001- | 1 | 2014 | 280 | 0.030 |
Why?
|
| Caregivers | 1 | 2004 | 2138 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 1781 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 1297 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2017 | 1749 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 934 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 1101 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9213 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 5997 | 0.020 |
Why?
|
| Oxygen | 1 | 2017 | 4182 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14125 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12217 | 0.010 |
Why?
|
| United States | 2 | 2015 | 70474 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 38800 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2019 | 53268 | 0.010 |
Why?
|
| Adolescent | 1 | 2000 | 86324 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 41409 | 0.010 |
Why?
|
| Child | 1 | 2014 | 78520 | 0.000 |
Why?
|
| Young Adult | 1 | 2012 | 57215 | 0.000 |
Why?
|